Table 1 Patients’ basic characteristics.
Median values; units | Total n = 241 |
|---|---|
Age, years (range) | 50.27 (24.46–78.84) |
BMI, kg/m2 (range) | 27.82 (18.51–50.15) |
Variables | n (%) |
|---|---|
< 40 yr-old patients | 45 (18.7) |
Hospital type | |
Public | 96 (39.8) |
Private | 145 (60.2) |
Type of health insurance | |
Public | 179 (75.2) |
Private | 59 (24.8) |
BMI category | |
Normal (< 25.0 kg/m2) | 64 (29.0) |
Overweight (25.0–29.99 kg/m2) | 79 (35.7) |
Obese (> 29.9 kg/m2) | 78 (35.3) |
Stage at diagnosis | |
Stage I or II | 124 (52.5) |
Stage III | 112 (47.5) |
BC subset | |
HR+/HER2− | 39 (16.2) |
HR+/HER2+ | 57 (23.7) |
HR−/HER2+ | 84 (34.9) |
HR−/HER2− | 61 (25.3) |
+ Lymph nodes | 155 (67.7) |
Type of chemotherapy | |
Anthracycline + Taxane | 222 (92.5) |
Anthracycline only | 3 (1.2) |
Taxane only | 15 (6.2) |
With childrena | 184 (85.2) |
+ Family historya | 151 (71.2) |
+ Ovarian cancera | 84 (39.8) |
+ Comorbiditiesa | 93 (47.4) |
+ Hypertensiona | 38 (18.7) |
+ Type-2 diabetesa | 15 (7.5) |
+ Hypothyroidisma | 22 (11.9) |
Use of metformina | 22 (12.4) |
Use of statinsa | 13 (7.5) |
Use of aspirina | 12 (6.9) |
+ Adjuvant hormone therapya | 61 (34.7) |
+ Adjuvant radiotherapya | 135 (91.8) |